Business Segments | Business Segments Our current reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare. We evaluate the performance of our operating segments and allocate resources to these segments based primarily on contribution margin, which we define as gross profit less advertising and marketing expenses. The tables below summarize information about our reportable segments. Three Months Ended September 30, 2024 (In thousands) North American OTC International OTC Consolidated Total segment revenues* $ 239,811 $ 43,974 $ 283,785 Cost of sales 107,782 18,621 126,403 Gross profit 132,029 25,353 157,382 Advertising and marketing 34,889 6,520 41,409 Contribution margin $ 97,140 $ 18,833 $ 115,973 Other operating expenses 31,634 Operating income $ 84,339 * Intersegment revenues of $0.9 million were eliminated from the North American OTC Healthcare segment. Six Months Ended September 30, 2024 (In thousands) North American OTC International OTC Consolidated Total segment revenues* 472,127 $ 78,800 $ 550,927 Cost of sales 213,341 34,182 247,523 Gross profit 258,786 44,618 303,404 Advertising and marketing 68,642 12,132 80,774 Contribution margin $ 190,144 $ 32,486 $ 222,630 Other operating expenses 66,245 Operating income $ 156,385 * Intersegment revenues of $1.6 million were eliminated from the North American OTC Healthcare segment. Three Months Ended September 30, 2023 (In thousands) North American OTC International OTC Consolidated Total segment revenues* $ 244,423 $ 41,893 $ 286,316 Cost of sales 107,466 18,830 126,296 Gross profit 136,957 23,063 160,020 Advertising and marketing 35,389 4,713 40,102 Contribution margin $ 101,568 $ 18,350 $ 119,918 Other operating expenses 31,668 Operating income $ 88,250 * Intersegment revenues of $0.6 million were eliminated from the North American OTC Healthcare segment. Six Months Ended September 30, 2023 (In thousands) North American OTC International OTC Consolidated Total segment revenues* $ 490,566 $ 75,059 $ 565,625 Cost of sales 217,542 33,390 250,932 Gross profit 273,024 41,669 314,693 Advertising and marketing 66,790 9,543 76,333 Contribution margin $ 206,234 $ 32,126 $ 238,360 Other operating expenses 64,916 Operating income $ 173,444 * Intersegment revenues of $2.0 million were eliminated from the North American OTC Healthcare segment. The tables below summarize information about our segment revenues from similar product groups. Three Months Ended September 30, 2024 (In thousands) North American OTC International OTC Consolidated Analgesics $ 27,147 $ 1,075 $ 28,222 Cough & Cold 23,054 6,221 29,275 Women's Health 54,309 6,038 60,347 Gastrointestinal 41,911 18,150 60,061 Eye & Ear Care 36,140 6,646 42,786 Dermatologicals 33,640 2,215 35,855 Oral Care 20,698 3,385 24,083 Other OTC 2,912 244 3,156 Total segment revenues $ 239,811 $ 43,974 $ 283,785 Six Months Ended September 30, 2024 (In thousands) North American OTC International OTC Consolidated Analgesics $ 54,158 $ 2,357 $ 56,515 Cough & Cold 38,015 11,957 49,972 Women's Health 104,804 10,121 114,925 Gastrointestinal 86,198 31,878 118,076 Eye & Ear Care 79,459 11,457 90,916 Dermatologicals 65,243 3,967 69,210 Oral Care 38,372 6,485 44,857 Other OTC 5,878 578 6,456 Total segment revenues $ 472,127 $ 78,800 $ 550,927 Three Months Ended September 30, 2023 (In thousands) North American OTC International OTC Consolidated Analgesics $ 29,976 $ 1,386 $ 31,362 Cough & Cold 25,970 7,263 33,233 Women's Health 55,000 7,072 62,072 Gastrointestinal 38,703 14,061 52,764 Eye & Ear Care 39,745 7,125 46,870 Dermatologicals 33,018 1,469 34,487 Oral Care 19,312 3,469 22,781 Other OTC 2,699 48 2,747 Total segment revenues $ 244,423 $ 41,893 $ 286,316 Six Months Ended September 30, 2023 (In thousands) North American OTC International OTC Consolidated Analgesics $ 57,158 $ 2,228 $ 59,386 Cough & Cold 46,344 13,315 59,659 Women's Health 109,955 12,028 121,983 Gastrointestinal 83,384 26,971 110,355 Eye & Ear Care 79,216 11,146 90,362 Dermatologicals 67,696 2,807 70,503 Oral Care 41,038 6,491 47,529 Other OTC 5,775 73 5,848 Total segment revenues $ 490,566 $ 75,059 $ 565,625 |